Valuation: Samsung Biologics Co.,Ltd.

Capitalization 77,260B 52.52B 44.69B 41.72B 39.14B 72.37B 4,738B 78.79B 486B 189B 2,238B 197B 193B 8,155B P/E ratio 2025 *
49.5x
P/E ratio 2026 * 41.6x
Enterprise value 76.01B 51.68M 43.97M 41.05M 38.51M 71.21M 4.66B 77.52M 478M 186M 2.2B 194M 190M 8.02B EV / Sales 2025 *
13.1x
EV / Sales 2026 * 11.7x
Free-Float
25.44%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.24%
1 week+66.90%
Current month+66.90%
1 month+66.90%
3 months+66.90%
6 months+66.90%
Current year+66.90%
More quotes
1 week 1,000,000
Extreme 999999.9999
1,693,000
1 month 1,000,000
Extreme 999999.9999
1,693,000
Current year 1,000,000
Extreme 999999.9999
1,693,000
1 year 1,000,000
Extreme 999999.9999
1,693,000
3 years 1,000,000
Extreme 999999.9999
1,693,000
5 years 1,000,000
Extreme 999999.9999
1,693,000
10 years 192,960.76
Extreme 192960.7607
1,693,000
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 08/12/2020
Director of Finance/CFO 57 13/03/2025
Investor Relations Contact 58 31/12/2013
Director TitleAgeSince
Chairman 64 08/12/2020
Director/Board Member 71 28/03/2022
Director/Board Member 66 19/03/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.24%+66.90%+66.90%+66.90% 52.43B
+1.69%+2.03%-4.59%-0.67% 74.51B
-1.55%-1.91%-36.59%-40.09% 58.22B
-0.62%+0.33%+33.76%+233.47% 53.6B
+0.65%-1.73%+13.57%-38.46% 26.05B
+0.49%-4.73%+32.03%+16.21% 18.68B
+0.18%-8.88%+119.27%+159.38% 18.39B
-0.66%-13.12%+42.61%+1,004.75% 16.61B
-0.04%-.--%+58.67%+154.72% 14.02B
+0.99%-1.99%+152.85%+702.57% 14.01B
Average +0.15%-1.70%+47.85%+225.88% 34.65B
Weighted average by Cap. +0.14%-0.63%+27.88%+128.61%
See all sector performances

Financials

2025 *2026 *
Net sales 5,803B 3.94B 3.36B 3.13B 2.94B 5.44B 356B 5.92B 36.51B 14.19B 168B 14.8B 14.49B 612B 6,367B 4.33B 3.68B 3.44B 3.23B 5.96B 390B 6.49B 40.06B 15.57B 184B 16.24B 15.9B 672B
Net income 1,633B 1.11B 944M 882M 827M 1.53B 100B 1.66B 10.27B 3.99B 47.29B 4.16B 4.08B 172B 1,893B 1.29B 1.1B 1.02B 959M 1.77B 116B 1.93B 11.91B 4.63B 54.84B 4.83B 4.73B 200B
Net Debt -1,245B -847M -720M -672M -631M -1.17B -76.36B -1.27B -7.84B -3.04B -36.07B -3.18B -3.11B -131B -2,601B -1.77B -1.5B -1.4B -1.32B -2.44B -159B -2.65B -16.36B -6.36B -75.34B -6.64B -6.49B -275B
More financial data * Estimated data
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
More about the company
Date Price Change Volume
10/12/25 1,669,000.00 +0.24% 55,438
10/12/25 1,665,000.00 +0.30% 34,891
09/12/25 1,660,000.00 +1.90% 44,895
08/12/25 1,629,000.00 -0.73% 36,652
05/12/25 1,641,000.00 -2.32% 54,357

End-of-day quote Korea S.E., December 10, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
1,669,000.00KRW
Average target price
2,203,354.67KRW
Spread / Average Target
+32.02%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock